Manandhar, N. R., Kayashta, G. K., & Acharya, P. K. (2018). Dasatinib tyrosine kinase inhibitor as second and third line therapy in chronic myeloid leukemia: outcome of a Nepalese study. Journal of Patan Academy of Health Sciences, 5(1), 47–56. https://doi.org/10.3126/jpahs.v5i1.24042